Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
The global Roxithromycin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Roxithromycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Roxithromycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Roxithromycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Roxithromycin include Hetero Healthcare, Finecure Pharmaceuticals, Zhejiang Zhenyuan Pharmaceutical, Johnson & Johnson, Hygeia Laboratories, Bayer AG, Allergan, Galderma SA and Valeant Pharmaceutical International, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Roxithromycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Roxithromycin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Roxithromycin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Roxithromycin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Roxithromycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Roxithromycin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Zhejiang Zhenyuan Pharmaceutical
Johnson & Johnson
Hygeia Laboratories
Bayer AG
Allergan
Galderma SA
Valeant Pharmaceutical International
Stiefel Laboratories
Cipher
Sigma-Aldrich
Hovione
Segment by Type
Roxithromycin Tablets
Roxithromycin Capsules
Roxithromycin Granules
Segment by Application
Respiratory Tract Infections
Urinary Infections
Soft Tissue Infections
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Roxithromycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Roxithromycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Roxithromycin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Roxithromycin Product Introduction
1.2 Market by Type
1.2.1 Global Roxithromycin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Roxithromycin Tablets
1.2.3 Roxithromycin Capsules
1.2.4 Roxithromycin Granules
1.3 Market by Application
1.3.1 Global Roxithromycin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Respiratory Tract Infections
1.3.3 Urinary Infections
1.3.4 Soft Tissue Infections
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Roxithromycin Sales Estimates and Forecasts 2019-2030
2.2 Global Roxithromycin Revenue by Region
2.2.1 Global Roxithromycin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Roxithromycin Revenue by Region (2019-2024)
2.2.3 Global Roxithromycin Revenue by Region (2025-2030)
2.2.4 Global Roxithromycin Revenue Market Share by Region (2019-2030)
2.3 Global Roxithromycin Sales Estimates and Forecasts 2019-2030
2.4 Global Roxithromycin Sales by Region
2.4.1 Global Roxithromycin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Roxithromycin Sales by Region (2019-2024)
2.4.3 Global Roxithromycin Sales by Region (2025-2030)
2.4.4 Global Roxithromycin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Roxithromycin Sales by Manufacturers
3.1.1 Global Roxithromycin Sales by Manufacturers (2019-2024)
3.1.2 Global Roxithromycin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Roxithromycin in 2023
3.2 Global Roxithromycin Revenue by Manufacturers
3.2.1 Global Roxithromycin Revenue by Manufacturers (2019-2024)
3.2.2 Global Roxithromycin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Roxithromycin Revenue in 2023
3.3 Global Key Players of Roxithromycin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Roxithromycin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Roxithromycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Roxithromycin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Roxithromycin, Product Offered and Application
3.8 Global Key Manufacturers of Roxithromycin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Roxithromycin Sales by Type
4.1.1 Global Roxithromycin Historical Sales by Type (2019-2024)
4.1.2 Global Roxithromycin Forecasted Sales by Type (2025-2030)
4.1.3 Global Roxithromycin Sales Market Share by Type (2019-2030)
4.2 Global Roxithromycin Revenue by Type
4.2.1 Global Roxithromycin Historical Revenue by Type (2019-2024)
4.2.2 Global Roxithromycin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Roxithromycin Revenue Market Share by Type (2019-2030)
4.3 Global Roxithromycin Price by Type
4.3.1 Global Roxithromycin Price by Type (2019-2024)
4.3.2 Global Roxithromycin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Roxithromycin Sales by Application
5.1.1 Global Roxithromycin Historical Sales by Application (2019-2024)
5.1.2 Global Roxithromycin Forecasted Sales by Application (2025-2030)
5.1.3 Global Roxithromycin Sales Market Share by Application (2019-2030)
5.2 Global Roxithromycin Revenue by Application
5.2.1 Global Roxithromycin Historical Revenue by Application (2019-2024)
5.2.2 Global Roxithromycin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Roxithromycin Revenue Market Share by Application (2019-2030)
5.3 Global Roxithromycin Price by Application
5.3.1 Global Roxithromycin Price by Application (2019-2024)
5.3.2 Global Roxithromycin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Roxithromycin Market Size by Type
6.1.1 US & Canada Roxithromycin Sales by Type (2019-2030)
6.1.2 US & Canada Roxithromycin Revenue by Type (2019-2030)
6.2 US & Canada Roxithromycin Market Size by Application
6.2.1 US & Canada Roxithromycin Sales by Application (2019-2030)
6.2.2 US & Canada Roxithromycin Revenue by Application (2019-2030)
6.3 US & Canada Roxithromycin Market Size by Country
6.3.1 US & Canada Roxithromycin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Roxithromycin Sales by Country (2019-2030)
6.3.3 US & Canada Roxithromycin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Roxithromycin Market Size by Type
7.1.1 Europe Roxithromycin Sales by Type (2019-2030)
7.1.2 Europe Roxithromycin Revenue by Type (2019-2030)
7.2 Europe Roxithromycin Market Size by Application
7.2.1 Europe Roxithromycin Sales by Application (2019-2030)
7.2.2 Europe Roxithromycin Revenue by Application (2019-2030)
7.3 Europe Roxithromycin Market Size by Country
7.3.1 Europe Roxithromycin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Roxithromycin Sales by Country (2019-2030)
7.3.3 Europe Roxithromycin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Roxithromycin Market Size
8.1.1 China Roxithromycin Sales (2019-2030)
8.1.2 China Roxithromycin Revenue (2019-2030)
8.2 China Roxithromycin Market Size by Application
8.2.1 China Roxithromycin Sales by Application (2019-2030)
8.2.2 China Roxithromycin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Roxithromycin Market Size by Type
9.1.1 Asia Roxithromycin Sales by Type (2019-2030)
9.1.2 Asia Roxithromycin Revenue by Type (2019-2030)
9.2 Asia Roxithromycin Market Size by Application
9.2.1 Asia Roxithromycin Sales by Application (2019-2030)
9.2.2 Asia Roxithromycin Revenue by Application (2019-2030)
9.3 Asia Roxithromycin Sales by Region
9.3.1 Asia Roxithromycin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Roxithromycin Revenue by Region (2019-2030)
9.3.3 Asia Roxithromycin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Roxithromycin Market Size by Type
10.1.1 Middle East, Africa and Latin America Roxithromycin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Roxithromycin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Roxithromycin Market Size by Application
10.2.1 Middle East, Africa and Latin America Roxithromycin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Roxithromycin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Roxithromycin Sales by Country
10.3.1 Middle East, Africa and Latin America Roxithromycin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Roxithromycin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Roxithromycin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hetero Healthcare
11.1.1 Hetero Healthcare Company Information
11.1.2 Hetero Healthcare Overview
11.1.3 Hetero Healthcare Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Hetero Healthcare Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hetero Healthcare Recent Developments
11.2 Finecure Pharmaceuticals
11.2.1 Finecure Pharmaceuticals Company Information
11.2.2 Finecure Pharmaceuticals Overview
11.2.3 Finecure Pharmaceuticals Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Finecure Pharmaceuticals Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Finecure Pharmaceuticals Recent Developments
11.3 Zhejiang Zhenyuan Pharmaceutical
11.3.1 Zhejiang Zhenyuan Pharmaceutical Company Information
11.3.2 Zhejiang Zhenyuan Pharmaceutical Overview
11.3.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Johnson & Johnson Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Hygeia Laboratories
11.5.1 Hygeia Laboratories Company Information
11.5.2 Hygeia Laboratories Overview
11.5.3 Hygeia Laboratories Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Hygeia Laboratories Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hygeia Laboratories Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Information
11.6.2 Bayer AG Overview
11.6.3 Bayer AG Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Bayer AG Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer AG Recent Developments
11.7 Allergan
11.7.1 Allergan Company Information
11.7.2 Allergan Overview
11.7.3 Allergan Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Allergan Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan Recent Developments
11.8 Galderma SA
11.8.1 Galderma SA Company Information
11.8.2 Galderma SA Overview
11.8.3 Galderma SA Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Galderma SA Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Galderma SA Recent Developments
11.9 Valeant Pharmaceutical International
11.9.1 Valeant Pharmaceutical International Company Information
11.9.2 Valeant Pharmaceutical International Overview
11.9.3 Valeant Pharmaceutical International Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Valeant Pharmaceutical International Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Valeant Pharmaceutical International Recent Developments
11.10 Stiefel Laboratories
11.10.1 Stiefel Laboratories Company Information
11.10.2 Stiefel Laboratories Overview
11.10.3 Stiefel Laboratories Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Stiefel Laboratories Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Stiefel Laboratories Recent Developments
11.11 Cipher
11.11.1 Cipher Company Information
11.11.2 Cipher Overview
11.11.3 Cipher Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Cipher Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cipher Recent Developments
11.12 Sigma-Aldrich
11.12.1 Sigma-Aldrich Company Information
11.12.2 Sigma-Aldrich Overview
11.12.3 Sigma-Aldrich Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Sigma-Aldrich Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sigma-Aldrich Recent Developments
11.13 Hovione
11.13.1 Hovione Company Information
11.13.2 Hovione Overview
11.13.3 Hovione Roxithromycin Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Hovione Roxithromycin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hovione Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Roxithromycin Industry Chain Analysis
12.2 Roxithromycin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Roxithromycin Production Mode & Process
12.4 Roxithromycin Sales and Marketing
12.4.1 Roxithromycin Sales Channels
12.4.2 Roxithromycin Distributors
12.5 Roxithromycin Customers
13 Market Dynamics
13.1 Roxithromycin Industry Trends
13.2 Roxithromycin Market Drivers
13.3 Roxithromycin Market Challenges
13.4 Roxithromycin Market Restraints
14 Key Findings in The Global Roxithromycin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Hetero Healthcare
Finecure Pharmaceuticals
Zhejiang Zhenyuan Pharmaceutical
Johnson & Johnson
Hygeia Laboratories
Bayer AG
Allergan
Galderma SA
Valeant Pharmaceutical International
Stiefel Laboratories
Cipher
Sigma-Aldrich
Hovione
听
听
*If Applicable.